tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PTCT Stock Latest News

PTC Therapeutics submits NDA for vatiquinone in Friedreich ataxia
The FlyPTC Therapeutics submits NDA for vatiquinone in Friedreich ataxia
2d ago
PTCT
PTC Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
PTC Therapeutics upgraded to Overweight from Equal Weight at Morgan Stanley
9d ago
PTCT
Cantor Fitzgerald says ‘aggressively’ buy uniQure, PTC Therapeutics
PremiumThe Fly
Cantor Fitzgerald says ‘aggressively’ buy uniQure, PTC Therapeutics
11d ago
PTCT
QURE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
17d ago
NVS
ESPR
PTC Therapeutics price target raised to $32 from $26 at Citi
PremiumThe Fly
PTC Therapeutics price target raised to $32 from $26 at Citi
18d ago
PTCT
PTC Therapeutics price target raised to $71 from $47 at UBS
PremiumThe FlyPTC Therapeutics price target raised to $71 from $47 at UBS
18d ago
NVS
PTCT
PTC Therapeutics price target raised to $70 from $52 at Baird
Premium
The Fly
PTC Therapeutics price target raised to $70 from $52 at Baird
19d ago
NVS
PTCT
PTC Therapeutics price target raised to $41 from $31 at BofA
Premium
The Fly
PTC Therapeutics price target raised to $41 from $31 at BofA
19d ago
NVS
PTCT
PTC Therapeutics price target raised to $41 from $31 at BofA
PremiumThe Fly
PTC Therapeutics price target raised to $41 from $31 at BofA
19d ago
NVS
PTCT
PTC Therapeutics price target raised to $56 from $45 at Barclays
PremiumThe Fly
PTC Therapeutics price target raised to $56 from $45 at Barclays
19d ago
PTCT
PTC Therapeutics’ Novartis deal expedites value creation, says Wells Fargo
PremiumThe Fly
PTC Therapeutics’ Novartis deal expedites value creation, says Wells Fargo
19d ago
NVS
PTCT
RBC upgrades PTC Therapeutics on ‘transformative’ Novartis deal
PremiumThe Fly
RBC upgrades PTC Therapeutics on ‘transformative’ Novartis deal
19d ago
NVS
PTCT
PTC Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
PremiumThe FlyPTC Therapeutics upgraded to Outperform from Sector Perform at RBC Capital
19d ago
PTCT
PTC Therapeutics Partners with Novartis for Huntington’s Program
Premium
Company Announcements
PTC Therapeutics Partners with Novartis for Huntington’s Program
19d ago
8K
PTCT
PTC Therapeutics enters global license, collaboration agreement with Novartis
Premium
The Fly
PTC Therapeutics enters global license, collaboration agreement with Novartis
19d ago
NVS
PTCT
PTC Therapeutics Sells Priority Review Voucher for $150M
PremiumCompany Announcements
PTC Therapeutics Sells Priority Review Voucher for $150M
24d ago
8K
PTCT
PTC Therapeutics price target raised to $52 from $48 at Baird
PremiumThe Fly
PTC Therapeutics price target raised to $52 from $48 at Baird
24d ago
PTCT
PTC Therapeutics to sell Priority Review Voucher for $150M
PremiumThe Fly
PTC Therapeutics to sell Priority Review Voucher for $150M
24d ago
PTCT
PTC Therapeutics: Phase 2 CardinALS study did not meet its primary endpoint
PremiumThe Fly
PTC Therapeutics: Phase 2 CardinALS study did not meet its primary endpoint
25d ago
PTCT
PTC Therapeutics price target raised to $62 from $51 at JPMorgan
PremiumThe FlyPTC Therapeutics price target raised to $62 from $51 at JPMorgan
1M ago
PTCT
PTC Therapeutics price target raised to $45 from $43 at Barclays
Premium
The Fly
PTC Therapeutics price target raised to $45 from $43 at Barclays
1M ago
PTCT
PTC Therapeutics’ AADC deficiency gene therapy granted FDA approval
Premium
The Fly
PTC Therapeutics’ AADC deficiency gene therapy granted FDA approval
1M ago
PTCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >